INCY Incyte Corporation - Common Stock
$125.70
मूल्य · अग 19, 2026
मौलिकता इस प्रकार है जुल 28, 2026
52W रेंज
$81–$133
87% of range
विश्लेषक रेटिंग
HOLD
33 analysts
मूल्य लक्ष्य
$125
P/E (TTM)
19.6
ROE
27.6%
शुद्ध लाभ मार्जिन
25.0%
Incyte Corporation - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
और पढ़ें
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.
History
Incyte Corporation was founded by Roy A. Whitfield on April 8, 1991, in Palo Alto, California, as a genomics company. It became a public company in 1993. Subsequently, scientists and chemists were recruited from DuPont to work for Incyte. Incyte moved its headquarters to Delaware, and acquired Maxia Pharmaceuticals in 2003.
In November 2013, Incyte announced its relocation to new headquarters in Wilmington, Delaware, completing the move by the end of 2014. Hervé Hoppenot became CEO in January 2014.
In 2017, the company became part of the S&P 500 Index, which tracks the 500 most widely held U.S. stocks.
In 2015, Incyte established its European headquarters in Geneva, Switzerland, and later moved this headquarters in 2021. The company expanded its Delaware headquarters, including the addition of a research and development facility, in 2022. Incyte acquired Villaris Therapeutics in 2022, and Escient Pharmaceuticals in 2024.
For 2025, the company reported $5.141 billion in revenue, $6.957 billion in assets and $1.286 billion in net income. Incyte is publicly traded on the NASDAQ under the symbol INCY. Incyte now operates out of North America, Asia, and Europe. Bill Meury became CEO in 2025. Meury replaced Hoppenot, who retired after 11 years in the position.
Pharmaceuticals
Incyte Corporation currently has seven marketed and co-marketed pharmaceutical products, including Jakafi (ruxolitinib), Pemazyre (pemigatinib), Monjuvi (tafasitamab-cxix), Opzelura (Ruxolitinib), Tabrecta (capmatinib), Olumiant (Baricitinib), and Iclusig (ponatinib).
In 2013, Novartis acquired Incyte's c-Met inhibitor capmatinib (INC280, INCB028060), which is marketed under the brand name Tabrecta.
As of 2014, the company was developing baricitinib, an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly. It gained EU approval in February 2017. In April 2017, the US FDA issued a rejection, citing concerns about dosing and safety. In May 2018, baricitinib was approved in the United States for the treatment of rheumatoid arthritis under the brand name Olumiant.
As of 2016 epacadostat, an indoleamine 2,3-dioxygenase (IDO1) inhibitor, was in development for various cancers and was in combination trials with Merck's pembrolizumab (Keytruda) and Bristol Myers Squibb's nivolumab (Opdivo).
Acquisition history
Incyte has made a total of 3 acquisitions.
Maxia Pharmaceuticals (2003): An early acquisition in Incyte's history, the company purchased Maxia in 2003 for $42 million.
Villaris Therapeutics (2022): This acquisition was valued at approximately $1.4 billion and included an upfront payment along with milestones. It added new assets to Incyte's portfolio for treating vitiligo and other autoimmune conditions.
Escient Pharmaceuticals (2024): In May 2024, Incyte acquired this San Diego-based, clinical-stage company for $750 million. The acquisition provided Incyte with two oral drug candidates for inflammatory diseases, EP262 and EP547.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
INCY स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$125.70
मार्केट कैप
$24.95B
P/E (TTM)
19.6
EPS (TTM)
$6.41
राजस्व (TTM)
$5.14B
लाभांश प्रतिफल
—
ROE
27.6%
D/E ऋण/इक्विटी
—
52W रेंज
$81 – $133
INCY स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
Configure
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व और शुद्ध आय
$5.14B
2016-12-31
→
2025-12-31
EPS
$6.41
2016-12-31
→
2025-12-31
फ्री कैश फ्लो
—
2017-12-31
→
2022-12-31
मार्जिन
25.0%
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
मेट्रिक
5Y रुझान
INCY
सहकर्मी माध्यिका
P/E (TTM)
19.6
17.7
P/S (TTM)
4.9
6.8
P/B
4.8
6.4
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
मेट्रिक
5Y रुझान
INCY
सहकर्मी माध्यिका
Operating Margin (परिचालन मार्जिन)
29.5%
—
Net Profit Margin (शुद्ध लाभ मार्जिन)
25.0%
20.3%
ROA
20.8%
11.4%
ROE
27.6%
16.8%
ROIC
22.7%
—
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
मेट्रिक
5Y रुझान
INCY
सहकर्मी माध्यिका
Current Ratio (वर्तमान अनुपात)
3.3
3.4
Quick Ratio (त्वरित अनुपात)
2.0
—
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
मेट्रिक
5Y रुझान
INCY
सहकर्मी माध्यिका
Revenue YoY (राजस्व YoY)
21.2%
—
Revenue CAGR 3Y (राजस्व CAGR 3Y)
14.8%
—
Revenue CAGR 5Y (राजस्व CAGR 5Y)
14.0%
—
EPS YoY
4173.3%
—
Net Income YoY (शुद्ध आय YoY)
3845.0%
—
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
मेट्रिक
5Y रुझान
INCY
सहकर्मी माध्यिका
INCY विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
खरीदें
33 विश्लेषक
- मजबूत खरीद 8 24.2%
- खरीदें 9 27.3%
- होल्ड 16 48.5%
- बेचें 0 0.0%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
23 विश्लेषक · 2026-08-18
मध्यिका
$120.00
अभी
$125.70
निम्न
$86.00
उच्च
$155.00
मध्यिका लक्ष्य
$120.00
-4.5%
माध्य लक्ष्य
$125.17
-0.4%
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
0.33%
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 30 जून 2026 | $3.09 | $2.14 | 0.95% |
| 31 मार्च 2026 | $1.81 | $1.40 | 0.41% |
| 31 दिसमबर 2025 | $1.80 | $1.97 | -0.17% |
| 30 सितमबर 2025 | $2.26 | $1.69 | 0.57% |
| 30 जून 2025 | $1.57 | $1.50 | 0.07% |
| 31 मार्च 2025 | $1.16 | $1.04 | 0.12% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| RVMD | — | — | — | — | — | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 17
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Cost of Revenue | $372M | $312M | $255M | $207M | $151M | $131M | $114M | $94M | $79M | $58M | $27M | $3M | |
| R&D Expense | $2.05B | $2.61B | $1.63B | $1.59B | $1.46B | $2.22B | $1.15B | $1.20B | $1.33B | $582M | $480M | $348M | |
| SG&A Expense | $1.38B | $1.24B | $1.16B | $1.00B | $740M | $517M | $469M | $434M | $366M | $303M | $197M | $166M | |
| Operating Expenses | $3.63B | $4.18B | $3.08B | $2.82B | $2.40B | $2.93B | $1.76B | $1.75B | $1.78B | $961M | $703M | $516M | |
| Operating Income | $1.51B | $61M | $621M | $579M | $586M | $-264M | $402M | $129M | $-243M | $145M | $51M | $-5M | |
| Interest Expense | · | · | $3M | $3M | $2M | $2M | $2M | $2M | $7M | $39M | $46M | $47M | |
| Interest Income | $106M | $129M | $158M | $40M | · | · | · | · | · | · | · | · | |
| Other Non-op | $25M | $13M | $14M | $-519.0K | $11M | $23M | $52M | $32M | $17M | · | · | · | |
| Pretax Income | $1.66B | $317M | $834M | $529M | $570M | $-232M | $487M | $115M | $-312M | $107M | $8M | $-49M | |
| Income Tax | $378M | $284M | $237M | $188M | $-378M | $63M | $40M | $6M | $852.0K | $3M | $1M | $-66.0K | |
| Net Income | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| EPS (Basic) | $6.59 | $0.16 | $2.67 | $1.53 | $4.30 | $-1.36 | $2.08 | $0.52 | $-1.53 | $0.55 | $0.04 | $-0.29 | |
| EPS (Diluted) | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 | $-1.36 | $2.05 | $0.51 | $-1.53 | $0.54 | $0.03 | $-0.29 | |
| Shares (Basic) | 195,204,000 | 207,110,000 | 223,628,000 | 222,004,000 | 220,428,000 | 218,073,000 | 214,913,000 | 212,383,000 | 204,580,000 | 187,873,000 | 179,601,000 | 167,947,000 | |
| Shares (Diluted) | 200,700,000 | 210,530,000 | 225,928,000 | 223,958,000 | 222,074,000 | 218,073,000 | 217,657,000 | 215,635,000 | 204,580,000 | 194,125,000 | 187,302,000 | 167,947,000 | |
| EBITDA | $1.61B | $151M | · | $647M | $644M | $-212M | $457M | $184M | $-192M | · | · | $37M |
बैलेंस शीट 27
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.10B | $1.69B | $3.21B | $2.95B | $2.06B | $1.51B | $1.83B | $1.16B | $900M | $652M | $521M | $452M | |
| Short-term Investments | · | · | · | · | · | · | $285M | $274M | $270M | $156M | $186M | $148M | |
| Inventory | $101M | $59M | $63M | $42M | $28M | $16M | $11M | $7M | $6M | $4M | $2M | $358.0K | |
| Prepaid Expense | $318M | $169M | $183M | $167M | $126M | $60M | $44M | $79M | $62M | $33M | $18M | $21M | |
| Current Assets | $5.02B | $3.24B | $4.65B | $4.09B | $3.12B | $2.36B | $2.48B | $1.83B | $1.50B | $994M | $842M | $680M | |
| PP&E (Net) | $731M | $763M | $752M | $739M | $724M | $560M | $378M | $320M | $260M | $168M | $86M | $82M | |
| PP&E (Gross) | $1.11B | $1.09B | $1.02B | $952M | $900M | $704M | $499M | $423M | $334M | $219M | $131M | $116M | |
| Accum. Depreciation | $375M | $328M | $270M | $213M | $176M | $144M | $122M | $103M | $75M | $52M | $45M | $35M | |
| Goodwill | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | $237M | $270M | $12M | $2M | |
| Other Non-current Assets | $18M | $11M | $52M | $25M | $37M | $39M | $49M | $19M | $2M | $3M | $12M | · | |
| Total Assets | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Accounts Payable | $210M | $197M | $110M | $278M | $172M | $99M | $84M | $104M | $68M | $76M | $30M | $24M | |
| Accrued Liabilities | $1.03B | $1.21B | $936M | $701M | $534M | $378M | $286M | $229M | $199M | $127M | $87M | $62M | |
| Current Liabilities | $1.52B | $1.64B | $1.24B | $1.16B | $854M | $631M | $513M | $425M | $375M | $274M | $168M | $221M | |
| Capital Leases | $15M | $17M | $14M | $14M | $16M | $14M | $12M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $20M | |
| Other Non-current Liabilities | $165M | $168M | $149M | $99M | $70M | $58M | $40M | $22M | $20M | $13M | $48M | $55M | |
| Total Liabilities | $1.79B | $2.00B | $1.59B | $1.47B | $1.16B | $950M | $828M | $720M | $672M | $1.22B | $836M | $878M | |
| Long-term Debt | · | · | · | · | · | · | · | $19.09B | $27M | $750M | $750M | $841M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $689M | |
| Common Stock | $198.0K | $193.0K | $224.0K | $223.0K | $221.0K | $219.0K | $216.0K | $213.0K | $211.0K | $189.0K | $187.0K | $171.0K | |
| Retained Earnings | $214M | $-1.07B | $160M | $-437M | $-778M | $-1.73B | $-1.43B | $-1.88B | $-1.99B | $-1.67B | $-1.78B | $-1.79B | |
| AOCI | $25M | $-13M | $13M | $15M | $-19M | $-15M | $-16M | $-10M | $-7M | $-3M | $-809.0K | $2M | |
| Stockholders' Equity | $5.17B | $3.45B | $5.19B | $4.37B | $3.77B | $2.61B | $2.60B | $1.93B | $1.63B | $419M | $171M | $-82M | |
| Liabilities + Equity | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Shares Outstanding | 198,460,009 | 193,434,305 | 224,286,862 | 222,746,719 | 221,084,433 | 219,489,329 | 216,177,830 | 213,274,660 | 211,262,906 | 188,848,752 | 186,650,249 | 170,876,619 |
नकदी प्रवाह 16
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $93M | $89M | $83M | $68M | $58M | $52M | $55M | $55M | $52M | $58M | $45M | $41M | |
| Stock-based Comp | $249M | $266M | $216M | $188M | $183M | $178M | $167M | $148M | $133M | $96M | $70M | $62M | |
| Deferred Tax | $248M | $-86M | $-159M | $57M | $-466M | $-350.0K | $-377.0K | $-459.0K | $-805.0K | · | · | · | |
| Amort. of Intangibles | $27M | $24M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $13M | · | · | |
| Other Non-cash | $-463M | $33M | · | $316M | $26M | $-58M | $43M | $24M | · | · | · | · | |
| Operating Cash Flow | $1.41B | $335M | $496M | $970M | $749M | $-125M | $711M | $336M | $-93M | $305M | $89M | $26M | |
| CapEx | · | · | · | $78M | $181M | $187M | $78M | $73M | $111M | $120M | $26M | $28M | |
| Investing Cash Flow | $-103M | $158M | $-208M | $-79M | $-208M | $-269M | $-87M | $-86M | $-350M | $-232M | $-105M | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $649M | · | · | · | |
| Stock Repurchased | $0 | $2.00B | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $0 | $-2.00B | · | · | · | · | · | · | $649M | · | · | · | |
| Financing Cash Flow | $101M | $-2.02B | $-20M | $-794.0K | $6M | $72M | $46M | $15M | $690M | $45M | $85M | · | |
| Net Change in Cash | $1.41B | $-1.53B | $262M | $894M | $544M | $-319M | $669M | $265M | $247M | $117M | $69M | $-19M | |
| Taxes Paid | $212M | $373M | $378M | $136M | $68M | $71M | $34M | $5M | $6M | $927.0K | · | · | |
| Free Cash Flow | · | · | · | $892M | $568M | $-312M | $633M | $263M | $-204M | · | · | $-2M | |
| Levered FCF | · | · | · | $890M | $565M | $-315M | $631M | $261M | $-211M | · | · | $-48M |
लाभप्रदता 7
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 29.5% | 1.5% | · | 17.1% | 19.6% | -9.9% | 18.6% | 6.9% | -15.9% | · | · | -0.94% | |
| Net Margin | 25.0% | 0.77% | · | 10.0% | 31.8% | -11.1% | 20.7% | 5.8% | · | · | · | · | |
| Pretax Margin | 32.4% | 7.5% | · | 15.6% | 19.1% | -8.7% | 22.6% | 6.1% | -20.3% | · | · | -9.5% | |
| EBITDA Margin | 31.3% | 3.5% | · | 19.1% | 21.6% | -7.9% | 21.1% | 9.8% | -12.5% | · | · | 7.2% | |
| ROA | 20.8% | 0.53% | · | 6.3% | 22.3% | -8.5% | 14.7% | 4.4% | · | · | · | · | |
| ROE | 27.6% | 0.99% | · | 7.9% | 27.4% | -11.8% | 17.8% | 5.9% | · | · | · | · | |
| ROIC | 22.7% | 0.18% | · | 8.5% | 25.8% | -12.9% | 14.2% | 6.4% | -15.0% | · | · | -0.79% |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 2.0 | · | 3.5 | 3.7 | 3.7 | 4.8 | 4.3 | 4.0 | · | · | 3.2 | |
| Quick Ratio | 2.0 | 1.0 | · | 2.6 | 2.4 | 2.4 | 4.1 | 3.4 | 3.1 | · | · | 2.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | -8.4 | |
| Interest Coverage | · | · | · | 217.3 | 307.0 | -121.3 | 216.7 | 83.7 | -35.3 | · | · | -0.1 |
दक्षता 2
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.6 | 0.7 | 0.8 | 0.7 | 0.8 | 0.8 | · | · | 0.7 | |
| Inventory Turnover | 4.7 | 5.1 | · | 5.9 | 6.8 | 9.4 | 12.4 | 14.0 | 15.0 | · | · | 7.9 |
विकास दरें 7
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 21.2% | 14.8% | 8.9% | 13.7% | 12.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 14.8% | 12.4% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 4173.3% | -94.3% | 74.3% | -64.4% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 61.6% | -67.2% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3845.0% | -94.5% | 75.4% | -64.1% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 55.7% | -67.5% | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 10
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Net Income TTM | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| Market Cap | $19.60B | $13.36B | · | $17.89B | $16.23B | $19.09B | $18.88B | $13.56B | $20.01B | · | · | · | |
| P/E | 15.4 | 460.5 | 23.7 | 52.8 | 17.2 | -64.0 | 42.6 | 124.7 | -61.9 | 185.7 | 3615.0 | -252.1 | |
| P/S | 3.8 | 3.2 | · | 5.3 | 5.4 | 7.2 | 8.7 | 7.2 | 13.0 | · | · | · | |
| P/B | 3.8 | 3.9 | · | 4.1 | 4.3 | 7.3 | 7.3 | 7.0 | 12.3 | · | · | · | |
| P / Tangible Book | 3.9 | 4.1 | 2.8 | 4.2 | 4.5 | 7.8 | · | · | · | · | · | · | |
| P / Cash Flow | 13.9 | 39.8 | · | 18.4 | 21.7 | -153.2 | 26.6 | 40.3 | -215.2 | · | · | · | |
| P / FCF | · | · | · | 20.1 | 28.5 | -61.2 | 29.8 | 51.6 | -98.1 | · | · | · | |
| Earnings Yield | 6.5% | 0.22% | 4.2% | 1.9% | 5.8% | -1.6% | 2.4% | 0.80% | -1.6% | 0.54% | 0.03% | -0.40% |
आय विवरण 17
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.67B | $1.27B | $1.51B | $1.37B | $1.22B | $1.05B | $1.18B | $1.14B | $1.04B | $881M | $1.01B | $919M | $955M | $809M | $927M | $823M | |
| Cost of Revenue | $105M | $105M | $121M | $99M | $79M | $73M | $88M | $86M | $77M | $61M | $70M | $60M | $68M | $57M | $59M | $55M | |
| R&D Expense | $517M | $516M | $611M | $507M | $495M | $437M | $466M | $573M | $1.14B | $429M | $444M | $376M | $401M | $407M | $501M | $384M | |
| SG&A Expense | $352M | $328M | $390M | $329M | $331M | $326M | $327M | $309M | $306M | $300M | $288M | $268M | $284M | $316M | $273M | $266M | |
| Operating Expenses | $976M | $972M | $1.17B | $922M | $685M | $848M | $877M | $992M | $1.52B | $789M | $826M | $704M | $761M | $784M | $857M | $685M | |
| Operating Income | $698M | $301M | $336M | $444M | $530M | $205M | $302M | $146M | $-478M | $92M | $187M | $215M | $194M | $25M | $70M | $138M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $430.0K | · | $623.0K | $655.0K | $469.0K | · | $641.0K | |
| Interest Income | $38M | $34M | $31M | $27M | $25M | $23M | $21M | $19M | $41M | $47M | · | · | · | · | · | · | |
| Other Non-op | $6M | $3M | $6M | $4M | $7M | $8M | $2M | $5M | $8M | $-2M | $-108M | $46M | $43M | $33M | $-14M | $12M | |
| Pretax Income | $752M | $344M | $390M | $482M | $558M | $234M | $314M | $157M | $-390M | $236M | $271M | $234M | $278M | $52M | $81M | $149M | |
| Income Tax | $166M | $40M | $91M | $58M | $153M | $76M | $113M | $50M | $55M | $67M | $70M | $63M | $74M | $30M | $52M | $36M | |
| Net Income | $586M | $303M | $299M | $424M | $405M | $158M | $201M | $106M | $-445M | $170M | $201M | $171M | $204M | $22M | $28M | $113M | |
| EPS (Basic) | $2.92 | $1.52 | $1.51 | $2.17 | $2.09 | $0.82 | $0.89 | $0.55 | $-2.04 | $0.76 | $0.90 | $0.76 | $0.91 | $0.10 | $0.12 | $0.51 | |
| EPS (Diluted) | $2.81 | $1.47 | $1.46 | $2.11 | $2.04 | $0.80 | $0.90 | $0.54 | $-2.04 | $0.75 | $0.89 | $0.76 | $0.90 | $0.10 | $0.13 | $0.50 | |
| Shares (Basic) | 200,378,000 | 199,343,000 | -388,173,000 | 195,670,000 | 193,995,000 | 193,712,000 | -428,178,000 | 192,629,000 | 218,175,000 | 224,484,000 | -446,658,000 | 224,078,000 | 223,248,000 | 222,960,000 | -443,397,000 | 222,415,000 | |
| Shares (Diluted) | 208,216,000 | 206,830,000 | -397,670,000 | 201,429,000 | 198,744,000 | 198,197,000 | -430,702,000 | 195,838,000 | 218,175,000 | 227,219,000 | -451,477,000 | 226,167,000 | 225,649,000 | 225,589,000 | -446,828,000 | 224,175,000 | |
| EBITDA | $698M | $325M | · | $444M | $530M | $228M | · | $146M | $-478M | $114M | · | $215M | $194M | $44M | · | $138M |
बैलेंस शीट 22
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.98B | $3.46B | $3.10B | $2.46B | $1.95B | $1.94B | $1.69B | $1.30B | $987M | $3.35B | · | $3.23B | $3.13B | $2.82B | · | $2.69B | |
| Inventory | $113M | $116M | $101M | $83M | $83M | $64M | $59M | $70M | $101M | $64M | · | $57M | $36M | $41M | · | $46M | |
| Prepaid Expense | $253M | $301M | $318M | $369M | $296M | $212M | $169M | $205M | $208M | $189M | · | $172M | $167M | $194M | · | $180M | |
| Current Assets | $6.03B | $5.48B | $5.02B | $4.28B | $3.64B | $3.51B | $3.24B | $2.81B | $2.57B | $4.85B | · | $4.40B | $4.26B | $3.97B | · | $3.82B | |
| PP&E (Net) | $709M | $720M | $731M | $799M | $799M | $765M | $763M | $773M | $762M | $720M | · | $733M | $749M | $742M | · | $716M | |
| PP&E (Gross) | $1.11B | $1.11B | $1.11B | $1.16B | $1.14B | $1.11B | $1.09B | $1.09B | $1.06B | $1.00B | · | $986M | $988M | $967M | · | $918M | |
| Accum. Depreciation | $404M | $389M | $375M | $361M | $346M | $344M | $328M | $316M | $298M | $283M | · | $253M | $239M | $226M | · | $202M | |
| Goodwill | $133M | $133M | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | $156M | $156M | $156M | · | $156M | |
| Other Non-current Assets | $87M | $24M | $18M | $32M | $33M | $30M | $11M | $40M | $22M | $47M | · | $81M | $32M | $21M | · | $24M | |
| Total Assets | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Accounts Payable | $250M | $229M | $210M | $172M | $241M | $196M | $197M | $179M | $148M | $164M | · | $139M | $156M | $56M | · | $163M | |
| Accrued Liabilities | $870M | $1.09B | $1.03B | $948M | $857M | $1.38B | $1.21B | $1.13B | $1.03B | $1.10B | · | $821M | $811M | $825M | · | $700M | |
| Current Liabilities | $1.31B | $1.49B | $1.52B | $1.34B | $1.28B | $1.72B | $1.64B | $1.50B | $1.34B | $1.40B | · | $1.12B | $1.12B | $1.01B | · | $1.01B | |
| Capital Leases | · | · | $15M | · | · | · | $17M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $125M | $127M | $165M | $171M | $180M | $176M | $168M | $145M | $142M | $151M | · | $133M | $140M | $118M | · | $75M | |
| Total Liabilities | $1.53B | $1.72B | $1.79B | $1.68B | $1.65B | $2.08B | $2.00B | $1.84B | $1.66B | $1.74B | · | $1.46B | $1.47B | $1.34B | · | $1.28B | |
| Common Stock | $201.0K | $200.0K | $198.0K | $196.0K | $194.0K | $193.0K | $193.0K | $192.0K | $191.0K | $224.0K | · | $224.0K | $223.0K | $223.0K | · | $222.0K | |
| Retained Earnings | $1.10B | $517M | $214M | $-86M | $-510M | $-915M | $-1.07B | $-1.27B | $-1.38B | $330M | · | $-41M | $-212M | $-416M | · | $-466M | |
| AOCI | $20M | $22M | $25M | $15M | $13M | $-6M | $-13M | $16M | $-5M | $-6M | · | $23M | $27M | $21M | · | $-29M | |
| Stockholders' Equity | $6.34B | $5.62B | $5.17B | $4.65B | $4.17B | $3.67B | $3.45B | $3.17B | $3.00B | $5.39B | $5.19B | $4.93B | $4.74B | $4.46B | $4.37B | $4.23B | |
| Liabilities + Equity | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Shares Outstanding | 200,977,687 | 199,948,401 | 198,460,009 | 196,130,993 | 194,123,265 | 193,783,446 | 193,434,305 | 192,798,328 | 191,572,449 | 224,533,449 | · | 224,101,839 | 223,338,330 | 223,061,787 | · | 222,454,839 |
नकदी प्रवाह 10
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $26M | $24M | $24M | $24M | $23M | $22M | $23M | $23M | $22M | $22M | $22M | $21M | $20M | $19M | $18M | $17M | |
| Stock-based Comp | $67M | $64M | $62M | $62M | $65M | $61M | $72M | $78M | $57M | $60M | $60M | $48M | $55M | $53M | $53M | $45M | |
| Other Non-cash | · | $-22M | · | · | · | $25M | · | · | · | $-32M | · | · | · | $-200M | · | · | |
| Operating Cash Flow | $508M | $369M | $543M | $559M | $45M | $266M | $381M | $311M | $-576M | $219M | $148M | $148M | $307M | $-106M | $284M | $296M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $28M | |
| Investing Cash Flow | $-52M | $-88M | $-37M | $-47M | $-19M | $1M | $-21M | $38M | $214M | $-73M | $-154M | $-17M | $-7M | $-29M | $-21M | $-28M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $103.0K | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $65M | $85M | $138M | $-13M | $-11M | $-13M | $20M | $-32M | $-2.00B | $-12M | $346.0K | $-37M | $13M | $4M | $-2M | $-14M | |
| Net Change in Cash | $521M | $363M | $643M | $500M | $13M | $254M | $384M | $317M | $-2.36B | $133M | $-14M | $96M | $310M | $-130M | $261M | $255M | |
| Taxes Paid | $15M | $-9M | $27M | $7M | $177M | $844.0K | $70M | $73M | $227M | $3M | $125M | $116M | $130M | $7M | $20M | $40M |
लाभप्रदता 7
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.7% | 23.7% | · | 32.5% | 43.6% | 19.5% | · | 12.8% | -45.8% | 10.4% | · | 23.4% | 20.3% | 3.1% | · | 16.8% | |
| Net Margin | 35.0% | 23.8% | · | 31.1% | 33.3% | 15.0% | · | 9.4% | -42.6% | 19.2% | · | 18.6% | 21.3% | 2.7% | · | 13.7% | |
| Pretax Margin | 44.9% | 27.0% | · | 35.3% | 45.9% | 22.2% | · | 13.8% | -37.3% | 26.8% | · | 25.4% | 29.1% | 6.4% | · | 18.1% | |
| EBITDA Margin | 41.7% | 25.5% | · | 32.5% | 43.6% | 21.6% | · | 12.8% | -45.8% | 12.9% | · | 23.4% | 20.3% | 5.4% | · | 16.8% | |
| ROA | 8.6% | 4.6% | · | 7.5% | 7.7% | 2.5% | · | 1.9% | -8.2% | 2.6% | · | 2.9% | 3.5% | 0.40% | · | 2.3% | |
| ROE | 11.1% | 6.5% | · | 10.8% | 11.3% | 3.5% | · | 2.6% | -11.5% | 3.4% | · | 3.7% | 4.6% | 0.52% | · | 3.1% | |
| ROIC | 8.6% | 4.7% | · | 8.4% | 9.2% | 3.8% | · | 3.1% | -18.2% | 1.2% | · | 3.2% | 3.0% | 0.23% | · | 2.5% |
तरलता और शोधन क्षमता 3
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 3.7 | · | 3.2 | 2.8 | 2.0 | · | 1.9 | 1.9 | 3.5 | · | 3.9 | 3.8 | 3.9 | · | 3.8 | |
| Quick Ratio | 3.0 | 2.3 | · | 1.8 | 1.5 | 1.1 | · | 0.9 | 0.7 | 2.4 | · | 2.9 | 2.8 | 2.8 | · | 2.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 213.7 | · | 344.6 | 295.8 | 52.8 | · | 215.9 |
दक्षता 2
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | |
| Inventory Turnover | 1.1 | 1.2 | · | 1.3 | 0.9 | 1.1 | · | 1.3 | 1.1 | 1.2 | · | 1.2 | 1.5 | 1.5 | · | 1.6 |
मूल्यांकन (TTM) 9
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.53B | $4.91B | · | $4.77B | $4.45B | $4.12B | · | $3.98B | $3.80B | $3.56B | · | $3.51B | $3.50B | $3.28B | · | $3.28B | |
| Net Income TTM | $1.72B | $1.29B | · | $1.09B | $225M | $-10M | · | $3M | $100M | $566M | · | $509M | $499M | $334M | · | $494M | |
| Market Cap | $22.78B | $18.82B | · | $16.63B | $13.22B | $11.73B | · | $12.74B | $11.61B | $12.79B | · | $12.95B | $13.90B | $16.12B | · | $14.82B | |
| P/E | 13.4 | 14.7 | · | 15.4 | 50.8 | 1211.0 | · | 6610.0 | 163.8 | 22.7 | · | 25.6 | 28.0 | 48.5 | · | 30.2 | |
| P/S | 4.1 | 3.8 | · | 3.5 | 3.0 | 2.9 | · | 3.2 | 3.1 | 3.6 | · | 3.7 | 4.0 | 4.9 | · | 4.5 | |
| P/B | 3.6 | 3.3 | · | 3.6 | 3.2 | 3.2 | · | 4.0 | 3.9 | 2.4 | · | 2.6 | 2.9 | 3.6 | · | 3.5 | |
| P / Tangible Book | 3.7 | 3.4 | · | 3.7 | 3.3 | 3.3 | · | 4.2 | 4.1 | 2.4 | · | 2.7 | 3.0 | 3.7 | · | 3.6 | |
| P / Cash Flow | · | 51.0 | · | · | · | 44.1 | · | · | · | 58.5 | · | · | · | -152.7 | · | · | |
| Earnings Yield | 7.4% | 6.8% | · | 6.5% | 2.0% | 0.08% | · | 0.02% | 0.61% | 4.4% | · | 3.9% | 3.6% | 2.1% | · | 3.3% |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| राजस्व | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B |
| परिचालन मार्जिन % | 29.5% | 1.5% | — | 17.1% | 19.6% |
| शुद्ध आय | $1.29B | $33M | $598M | $341M | $949M |
| तनुकरणित EPS | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 |
बैलेंस शीट
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 3.3 | 2.0 | — | 3.5 | 3.7 |
| त्वरित अनुपात | 2.0 | 1.0 | — | 2.6 | 2.4 |
नकदी प्रवाह
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | — | — | — | $892M | $568M |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
ट्रेडिंग सिग्नल प्रवेश मूल्य और जोखिम/इनाम अनुपात के साथ हालिया खरीद/बिक्री संकेत
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
📊
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 928 फाइलर्स · $16.2B कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 129 (+10 पिछली तिमाही की तुलना में) | 66 (-31 पिछली तिमाही की तुलना में) | 345 (+31 पिछली तिमाही की तुलना में) | 261 (-21 पिछली तिमाही की तुलना में) | +18.0M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $3487217729 | 30762330 | 21.56% | शेयर |
| Dodge & Cox | $1355482475 | 11957326 | 8.38% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $1249713401 | 11024289 | 7.73% | शेयर |
| STATE STREET CORP | $1102124009 | 9722336 | 6.81% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $883198076 | 7791091 | 5.46% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $472254570 | 4183857 | 2.92% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $398135284 | 3512132 | 2.46% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $384786803 | 3394379 | 2.38% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $311168439 | 2744958 | 1.92% | शेयर |
| Robeco Institutional Asset Management B.V. | $276795075 | 2441735 | 1.71% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $227123448 | 2003559 | 1.40% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $201199603 | 1774874 | 1.24% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $191845249 | 1692354 | 1.19% | शेयर |
| FIRST TRUST ADVISORS LP | $180015041 | 1587996 | 1.11% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $167811569 | 1480342 | 1.04% | शेयर |
| Caisse de depot et placement du Quebec | $155360220 | 1370503 | 0.96% | शेयर |
| AustralianSuper Pty Ltd | $135634220 | 1196491 | 0.84% | शेयर |
| NORGES BANK | $126861970 | 1119107 | 0.78% | शेयर |
| FMR LLC | $116316542 | 1026081 | 0.72% | शेयर |
| ROYAL BANK OF CANADA | $115263000 | 1016790 | 0.71% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $106959694 | 943540 | 0.66% | शेयर |
| ARMISTICE CAPITAL, LLC | $102024567 | 900005 | 0.63% | शेयर |
| PANAGORA ASSET MANAGEMENT INC | $99970937 | 881889 | 0.62% | शेयर |
| GOLDMAN SACHS GROUP INC | $97568045 | 860692 | 0.60% | शेयर |
| VANGUARD GROUP INC | $91396622 | 925348 | 0.56% | शेयर |
| Sound Shore Management Inc /CT/ | $85895479 | 757723 | 0.53% | शेयर |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $82953901 | 731774 | 0.51% | शेयर |
| Gotham Asset Management, LLC | $81567621 | 719545 | 0.50% | शेयर |
| Pictet Asset Management Holding SA | $81315880 | 713354 | 0.50% | शेयर |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $75887460 | 768325 | 0.47% | शेयर |
| MACKENZIE FINANCIAL CORP | $71967956 | 634862 | 0.44% | शेयर |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $65633852 | 578986 | 0.41% | शेयर |
| Legal & General Group Plc | $63331398 | 558675 | 0.39% | शेयर |
| SEB Asset Management AB | $63307742 | 558467 | 0.39% | शेयर |
| GLENMEDE TRUST CO NA | $60308653 | 532010 | 0.37% | शेयर |
| Woodline Partners LP | $58118538 | 512690 | 0.36% | शेयर |
| MARSHALL WACE, LLP | $56804130 | 501095 | 0.35% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $56779870 | 500881 | 0.35% | शेयर |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $55184782 | 486810 | 0.34% | शेयर |
| BlackRock, Inc. | $54675002 | 482313 | 0.34% | शेयर |
| Swiss National Bank | $54058437 | 476874 | 0.33% | शेयर |
| Glenmede Investment Management, LP | $53145338 | 626640 | 0.33% | शेयर |
| Vinva Investment Management Ltd | $53069578 | 462843 | 0.33% | शेयर |
| CANADA PENSION PLAN INVESTMENT BOARD | $50161800 | 442500 | 0.31% | शेयर |
| California Public Employees Retirement System | $48730290 | 429872 | 0.30% | शेयर |
| RHUMBLINE ADVISERS | $48578406 | 428533 | 0.30% | शेयर |
| IEQ CAPITAL, LLC | $48141997 | 424682 | 0.30% | शेयर |
| Mitsubishi UFJ Asset Management Co., Ltd. | $46733567 | 412258 | 0.29% | शेयर |
| Sumitomo Mitsui Trust Group, Inc. | $44634140 | 393738 | 0.28% | शेयर |
| Vanguard Global Advisers, LLC | $43080994 | 380037 | 0.27% | शेयर |
| MORGAN STANLEY | $42894746 | 378394 | 0.27% | शेयर |
| Swedbank AB | $42100431 | 371387 | 0.26% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $39177443 | 345602 | 0.24% | शेयर |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $38530157 | 339892 | 0.24% | शेयर |
| CAPITAL FUND MANAGEMENT S.A. | $38125008 | 336318 | 0.24% | शेयर |
| VANGUARD ASSET MANAGEMENT, Ltd | $37984782 | 335081 | 0.23% | शेयर |
| Grantham, Mayo, Van Otterloo & Co. LLC | $36114682 | 318584 | 0.22% | शेयर |
| Aware Super Pty Ltd as trustee of Aware Super | $34779982 | 306810 | 0.21% | शेयर |
| Arbejdsmarkedets Tillaegspension | $33826624 | 298400 | 0.21% | शेयर |
| BARCLAYS PLC | $32329252 | 285191 | 0.20% | शेयर |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $32129398 | 283428 | 0.20% | शेयर |
| Ensign Peak Advisors, Inc | $30602212 | 269956 | 0.19% | शेयर |
| Illinois Municipal Retirement Fund | $29511916 | 260338 | 0.18% | शेयर |
| WINTON GROUP Ltd | $28839691 | 254408 | 0.18% | शेयर |
| PFA Pension, Forsikringsaktieselskab | $28624373 | 252509 | 0.18% | शेयर |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $26717581 | 236172 | 0.17% | शेयर |
| TODD ASSET MANAGEMENT LLC | $26568750 | 234375 | 0.16% | शेयर |
| BANK OF AMERICA CORP /DE/ | $25899133 | 228468 | 0.16% | शेयर |
| PRINCIPAL FINANCIAL GROUP INC | $24961078 | 220193 | 0.15% | शेयर |
| Andra AP-fonden | $24381598 | 259048 | 0.15% | शेयर |
| Quantinno Capital Management LP | $24309704 | 214446 | 0.15% | शेयर |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $24037194 | 212043 | 0.15% | शेयर |
| Baird Financial Group, Inc. | $23690539 | 208985 | 0.15% | शेयर |
| Eurizon Capital SGR S.p.A. | $23250000 | 204785 | 0.14% | शेयर |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $22709932 | 241287 | 0.14% | शेयर |
| Korea Investment CORP | $22164827 | 195526 | 0.14% | शेयर |
| KLP KAPITALFORVALTNING AS | $21799695 | 192305 | 0.13% | शेयर |
| Catalio Capital Management, LP | $21722837 | 191627 | 0.13% | शेयर |
| PRUDENTIAL FINANCIAL INC | $21650853 | 190992 | 0.13% | शेयर |
| ROYAL LONDON ASSET MANAGEMENT LTD | $21575016 | 190323 | 0.13% | शेयर |
| Fideuram Asset Management (Ireland) dac | $20928446 | 213883 | 0.13% | शेयर |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $20401285 | 179969 | 0.13% | शेयर |
| APG Asset Management N.V. | $20193310 | 203661 | 0.12% | शेयर |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $19499734 | 172016 | 0.12% | शेयर |
| SECTOR GAMMA AS | $19356560 | 170753 | 0.12% | शेयर |
| MARTINGALE ASSET MANAGEMENT L P | $19137209 | 168818 | 0.12% | शेयर |
| CWM, LLC | $19084906 | 202772 | 0.12% | शेयर |
| Bridgewater Associates, LP | $19073160 | 168253 | 0.12% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $18937791 | 201209 | 0.12% | शेयर |
| Candriam S.C.A. | $18443367 | 162854 | 0.11% | शेयर |
| Focus Partners Wealth | $18354947 | 161917 | 0.11% | शेयर |
| DNB Asset Management AS | $18304239 | 161470 | 0.11% | शेयर |
| SEI INVESTMENTS CO | $18019140 | 158955 | 0.11% | शेयर |
| Trails Edge Capital Partners, LP | $17570800 | 155000 | 0.11% | शेयर |
| Jefferies Financial Group Inc. | $17321295 | 152799 | 0.11% | शेयर |
| SAWGRASS ASSET MANAGEMENT LLC | $17250671 | 152176 | 0.11% | शेयर |
| Mitsubishi UFJ Trust & Banking Corp | $17215756 | 151868 | 0.11% | शेयर |
| AVIVA PLC | $16882025 | 148924 | 0.10% | शेयर |
| Driehaus Capital Management LLC | $16794397 | 148151 | 0.10% | शेयर |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $16681037 | 147151 | 0.10% | शेयर |
कंपनी के अंदरूनी सूत्र 61 इनसाइडर्स · 32 अधिकारी · 17 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| William Meury | Chief Executive Officer | 16 जुलाई 2026 A | 183129 | 0 | 0 | $0 |
| Herve Hoppenot | Special Advisor to the CEO | 15 जुलाई 2025 F | 517146 | 0 | 0 | $0 |
| Christiana Stamoulis | EVP & Chief Financial Officer | 15 जुलाई 2025 A | 125759 | 0 | 0 | $0 |
| David W Gryska | Executive Vice President, CFO | 16 जुलाई 2018 F | 10235 | 0 | 0 | $0 |
| David C Hastings | Chief Financial Officer | 5 जून 2014 M | 8500 | 0 | 0 | $0 |
| Lee Heeson | EVP, Head of Incyte Intl | 23 जुलाई 2026 A | 32778 | 0 | 0 | $0 |
| Michael James Morrissey | EVP, Head of Tech. Operations | 23 जुलाई 2026 A | 81515 | 0 | 0 | $0 |
| Richard A. Hoffman | EVP & General Counsel | 16 जुलाई 2026 A | 16861 | 0 | 0 | $0 |
| David H Gardner | EVP, Chief Strategy Officer | 16 जुलाई 2026 A | 16824 | 0 | 0 | $0 |
| Ramitpal K Basi | EVP, Human Resources | 16 जुलाई 2026 A | 11497 | 0 | 0 | $0 |
| Mohamed Khairie Issa | EVP, Head of U.S. Commercial | 16 जुलाई 2026 A | 71797 | 0 | 1 | $-125706 |
| Thomas Tray | Principal Accounting Officer | 16 जुलाई 2026 A | 21699 | 0 | 1 | $-263900 |
| Steven H Stein | CMO & Head of Late-Stage Dev. | 16 जुलाई 2026 A | 30916 | 0 | 2 | $-3407541 |
| Sheila A. Denton | EVP & General Counsel | 15 अगस्त 2025 M | 33200 | 0 | 1 | $-24046 |
| Vijay K Iyengar | EVP, GMAPPS | 16 जुलाई 2025 S | 40540 | 0 | 0 | $0 |
| Barry P Flannelly | EVP & General Manager US | 16 जुलाई 2025 S | 35149 | 0 | 0 | $0 |
| Matteo Trotta | EVP, GM, Dermatology US | 15 जुलाई 2025 A | 15016 | 0 | 0 | $0 |
| Paula J Swain | EVP, Human Resources | 15 जुलाई 2025 A | 106482 | 0 | 0 | $0 |
| Jonathan Elliott Dickinson | EVP, General Manager, Europe | 12 सितमबर 2024 S | 36390 | 0 | 0 | $0 |
| Dashyant Dhanak | EVP & Chief Scientific Officer | 14 जुलाई 2023 A | 58968 | 0 | 0 | $0 |
| Maria E Pasquale | EVP & General Counsel | 14 जुलाई 2023 A | 69724 | 0 | 0 | $0 |
| Paul Trower | Principal Accounting Officer | 19 जनवरी 2022 A | 32268 | 0 | 0 | $0 |
| Yao Wenqing | EVP, Head of Discovery Chem | 2 जुलाई 2021 A | 98575 | 0 | 0 | $0 |
| Reid M Huber | EVP, Chief Scientific Officer | 16 जुलाई 2018 F | 34571 | 0 | 0 | $0 |
| Eric H. Siegel | EVP, General Counsel | 13 सितमबर 2017 F | 21053 | 0 | 0 | $0 |
| Richard S Levy | EVP, Chief Drug Dev Officer | 6 जनवरी 2016 M | 16926 | 0 | 0 | $0 |
| James M Daly | EVP, Chief Commercial Officer | 23 जून 2015 M | 3521 | 0 | 0 | $0 |
| Patricia S Andrews | Chief Commercial Officer | 19 जनवरी 2012 A | — | 0 | 0 | $0 |
| Patricia A Schreck | EVP, General Counsel | 10 मई 2011 M | 4500 | 0 | 0 | $0 |
| Brian W Metcalf | Chief Drug Discovery Scientist | 11 अप्रैल 2011 M | 66504 | 0 | 0 | $0 |
| Steven M. Friedman | EVP, Biology & Preclinical Dev | 18 मई 2010 A | 38137 | 0 | 0 | $0 |
| John A Keller | Chief Business Officer | 8 फ़रवरी 2008 A | — | 0 | 0 | $0 |
| Paul J Clancy | निदेशक | 30 जून 2026 A | 25635 | 0 | 0 | $0 |
| Edmund Harrigan | निदेशक | 30 जून 2026 A | 23019 | 0 | 0 | $0 |
| Katherine A High | निदेशक | 8 जून 2026 A | 14983 | 0 | 0 | $0 |
| Jacqualyn A Fouse | निदेशक | 8 जून 2026 A | 20968 | 0 | 0 | $0 |
| Jean Jacques Bienaime | निदेशक | 8 जून 2026 A | 24424 | 0 | 0 | $0 |
| Otis W Brawley | निदेशक | 8 जून 2026 A | 12894 | 0 | 0 | $0 |
| Susanne Schaffert | निदेशक | 12 जून 2024 A | 5720 | 0 | 0 | $0 |
| Wendy L Dixon | निदेशक | 31 मार्च 2022 A | 17768 | 0 | 0 | $0 |
| Paul A Friedman, M.D. | निदेशक | 26 मई 2020 A | 256813 | 0 | 0 | $0 |
| Paul A Brooke | निदेशक | 31 मार्च 2020 A | 221911 | 0 | 0 | $0 |
| Barry A Ariko | निदेशक | 12 मार्च 2015 M | 45834 | 0 | 0 | $0 |
| Richard U De Schutter | निदेशक | 5 मार्च 2015 M | 92290 | 0 | 0 | $0 |
| Roy A Whitfield | निदेशक | 17 दिसमबर 2013 M | 666082 | 0 | 0 | $0 |
| John F Niblack | निदेशक | 20 मई 2011 A | — | 0 | 0 | $0 |
| Fred B Craves | निदेशक | 1 जून 2005 A | 196793 | 0 | 0 | $0 |
| INCYTE CORP | 10% मालिक | 25 जनवरी 2021 A | 3550000 | 0 | 0 | $0 |
| DAMIAL FOUNDATION INC | 10% मालिक | 11 फ़रवरी 2004 S | — | 0 | 0 | $0 |
| Bonnie J Tisch | 10% मालिक | 14 जनवरी 2004 S | — | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
कार्यकर्ता और 5%+ मालिक 7 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB3 LLC, FBB Associates ×21 फाइलिंग | 11 मई 2026 | 15.60% | संशोधन | निष्क्रिय निवेश | SEC |
| Incyte Corporation ×3 फाइलिंग | 14 अगस्त 2023 | — | प्रारंभिक फाइलिंग | पूंजी संरचना | SEC |
| Baker Bros. Advisors, LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB Associates ×2 फाइलिंग | 15 जून 2012 | — | प्रारंभिक फाइलिंग | — | SEC |
| Julian C. Baker, Felix J. Baker ×12 फाइलिंग | 1 अक्टूबर 2009 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 25 फ़रवरी 2004 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 29 सितमबर 2003 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 15 अगस्त 2002 | — | प्रारंभिक फाइलिंग | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ईटीएफ स्वामित्व 214 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| IDNA · iShares Trust | 4.05% | 67570 SH | 8 अगस्त 2026 | दैनिक |
| BRNY · EA Series Trust | 3.64% | 211562 NS | 30 अप्रैल 2026 | N-PORT |
| PBE · Invesco Exchange-Traded Fund Trust | 2.97% | 89311 SH | 8 अगस्त 2026 | दैनिक |
| BUL · Pacer Funds Trust | 2.38% | 31787 NS | 30 अप्रैल 2026 | N-PORT |
| SAWG · ETF Series Solutions | 2.36% | 624 NS | 30 अप्रैल 2026 | N-PORT |
| UPGD · Invesco Exchange-Traded Fund Trust | 2.32% | 23365 SH | 8 अगस्त 2026 | दैनिक |
| FXH · First Trust Exchange-Traded AlphaDE… | 2.19% | 201047 NS | 30 अप्रैल 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1.98% | 623 NS | 30 अप्रैल 2026 | N-PORT |
| SMRI · EA Series Trust | 1.96% | 111283 NS | 30 अप्रैल 2026 | N-PORT |
| IBB · iShares Trust | 1.81% | 1453479 SH | 8 अगस्त 2026 | दैनिक |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.78% | 9967 NS | 30 अप्रैल 2026 | N-PORT |
| RPG · Invesco Exchange-Traded Fund Trust | 1.75% | 293364 SH | 8 अगस्त 2026 | दैनिक |
| SPGP · Invesco Exchange-Traded Fund Trust | 1.75% | 337040 SH | 8 अगस्त 2026 | दैनिक |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.73% | 112472 SH | 8 अगस्त 2026 | दैनिक |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1.64% | 10873 SH | 8 अगस्त 2026 | दैनिक |
| BBP · ETFis Series Trust I | 1.59% | 9918 NS | 30 अप्रैल 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1.59% | 736 NS | 30 अप्रैल 2026 | N-PORT |
| CALF · Pacer Funds Trust | 1.55% | 561166 NS | 30 अप्रैल 2026 | N-PORT |
| NUMG · Nushares ETF Trust | 1.44% | 53580 NS | 30 अप्रैल 2026 | N-PORT |
| AGNG · Global X Funds | 1.36% | 11515 NS | 31 मई 2026 | N-PORT |
| COWG · Pacer Funds Trust | 1.21% | 275493 NS | 30 अप्रैल 2026 | N-PORT |
| FLOW · Global X Funds | 1.20% | 3543 NS | 31 मई 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 1.16% | 113960 SH | 8 अगस्त 2026 | दैनिक |
| GURU · Global X Funds | 1.01% | 6203 NS | 30 अप्रैल 2026 | N-PORT |
| BIB · ProShares Trust | 0.97% | 7359 NS | 31 मई 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.94% | 51287 NS | 30 अप्रैल 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0.94% | 3113 NS | 31 मई 2026 | N-PORT |
| OASC · Unified Series Trust | 0.91% | 7915 NS | 31 मई 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0.89% | 56482 NS | 30 अप्रैल 2026 | N-PORT |
| ROE · EA Series Trust | 0.87% | 23347 NS | 29 मई 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 0.83% | 1595 NS | 30 अप्रैल 2026 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 0.80% | 8654 SH | 8 अगस्त 2026 | दैनिक |
| JOET · Virtus ETF Trust II | 0.79% | 19541 NS | 30 अप्रैल 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0.75% | 61119 NS | 30 अप्रैल 2026 | N-PORT |
| CLSE · Trust for Professional Managers | 0.71% | 45326 NS | 31 मई 2026 | N-PORT |
| SDG · iShares Trust | 0.70% | 10188 SH | 8 अगस्त 2026 | दैनिक |
| FTC · First Trust Exchange-Traded AlphaDE… | 0.64% | 85796 NS | 30 अप्रैल 2026 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 0.64% | 146423 NS | 31 मई 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.53% | 2249253 SH | 8 अगस्त 2026 | दैनिक |
| EBI · RBB Fund Trust | 0.52% | 35279 NS | 31 मई 2026 | N-PORT |
| ESMV · iShares Trust | 0.51% | 339 SH | 8 अगस्त 2026 | दैनिक |
| TECB · iShares Trust | 0.48% | 19516 SH | 8 अगस्त 2026 | दैनिक |
| AFMC · First Trust Exchange-Traded Fund VI… | 0.48% | 7994 NS | 31 मई 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0.46% | 19147 SH | 8 अगस्त 2026 | दैनिक |
| USMV · iShares Trust | 0.45% | 918818 SH | 8 अगस्त 2026 | दैनिक |
| AFLG · First Trust Exchange-Traded Fund VI… | 0.45% | 29860 NS | 31 मई 2026 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 0.44% | 4411 NS | 31 मई 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 0.44% | 832413 NS | 30 अप्रैल 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 0.43% | 2130 NS | 30 अप्रैल 2026 | N-PORT |
| HQGO · Lattice Strategies Trust | 0.42% | 2110 NS | 30 अप्रैल 2026 | N-PORT |